Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis.

In the United States, out-of-pocket (OOP) costs of brand-name medications for neurological disorders increased significantly ...

Out-of-pocket costs for branded drugs to treat multiple sclerosis (MS), Alzheimer's, and Parkinson's disease rose from 2012 ...

The condition affects roughly six million Americans, although experts believe the real number may be closer to 30 million.

Silvana Lopes Costa, PhD, of Kessler Foundation was awarded the prestigious Women in Neurodegenerative Disease Rehabilitation ...

The capabilities of artificial intelligence continue to advance rapidly, and the medical field is no exception.Baptist Health ...

A common yet underdiagnosed sleep disorder contributes to the development of dementia among adults -; particularly women, a ...

FRIDAY, Nov. 1, 2024 (HealthDay News) -- Sleep apnea appears to increase a person's odds of developing dementia, a new study finds ... who directs the Multiple Sclerosis/Neuroimmunology Division at ...

If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring treatment options. You've got a lot of them, everything from disease-modifying therapies and drugs that help manage ...

The goal of multiple sclerosis (MS) treatment is to slow or stop the immune system's attack on the nervous system. Though several new medications have been approved in recent years that are effective ...